Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

C4 Therapeutics (CCCC) Return on Invested Capital (2020 - 2024)

C4 Therapeutics (CCCC) has 5 years of Return on Invested Capital data on record, last reported at 0.52% in Q4 2024.

  • For Q4 2024, Return on Invested Capital rose 9.0% year-over-year to 0.52%; the TTM value through Dec 2024 reached 0.52%, up 9.0%, while the annual FY2025 figure was 0.49%, 3.0% up from the prior year.
  • Return on Invested Capital reached 0.52% in Q4 2024 per CCCC's latest filing, down from 0.49% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.37% in Q3 2020 and bottomed at 0.89% in Q4 2020.
  • Average Return on Invested Capital over 5 years is 0.43%, with a median of 0.49% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: fell -20bps in 2023, then grew 12bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.89% in 2020, then skyrocketed by 72bps to 0.25% in 2021, then tumbled by -64bps to 0.41% in 2022, then plummeted by -48bps to 0.61% in 2023, then rose by 14bps to 0.52% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.52% in Q4 2024, 0.49% in Q3 2024, and 0.48% in Q2 2024.